Pharma News, 2024

The FDA granted an orphan drug designation to PLT012 (Pilatus Biosciences) for the treatment of patients with liver and intrahepatic bile duct cancer (HCC/ICCA).

COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company with a market capitalization of just under $7 million, has announced preclinical Proof-of-Concept (P...

China’s National Medical Products Administration (NMPA) has approved Santhera Pharmaceuticals’ AGAMREE (vamorolone), used to treat Duchenne muscular dystrophy (DMD) in pati...

If accepted, Vifor Pharma's £23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.

The FDA has granted fast track designations to 2 combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and older.

C4 Therapeutics (CCCC) presented clinical data from the ongoing Phase 1 trial of cemsidomide, an orally bioavailable small molecule degrader of IKZF1/3, at the ASH Annual Meeting.

FOSTER CITY, Calif. - Geron Corporation , a biopharmaceutical company with a market capitalization of $2.4 billion and an impressive 92% stock return over the past year, today revealed new data fr...

Ensem Therapeutics To Present Preclinical Data for Potential Best-in-Class Oral CDK2 Inhibitor at San Antonio Breast Cancer Symposium

Citryll has secured an oversubscribed Series B funding round, raising €85m ($89.8m) to advance the clinical development of the first-in-class monoclonal antibody, CIT-013, designed to target...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Daiichi Sankyo for its antibody-drug conjugate (ADC) datopotamab deruxtecan, which is designed...

Goal: Advance lead therapy into Phase 1 testing in patients by mid-2025.

Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity. The study published in Nature shows the drastic economic cost of obesity through...